Metandienone Wikipedia
Key Take‑away

Metabolite‑based oral agents that act on the androgen receptor are typically prescription‑only drugs with a narrow therapeutic window. They are approved for specific clinical indications, have well‑characterised pharmacokinetics and a defined safety profile, but carry significant risks of hormonal side‑effects and may be abused or diverted in non‑clinical settings.


Below is a concise "cheat sheet" that covers the major aspects you need to know as a healthcare professional.

---

1. FDA/EMA Approved Indications

DrugApproved Uses (U.S.)Expanded Uses (Europe) Enobosarm (Ovolutamab)Investigational – early‑phase trials for androgenic alopecia and sarcopeniaPhase II studies: breast cancer, muscle wasting TirbanibulinNot a SARM